title: What are the problems with using the peritoneal membrane for long-term dialysis?
authors.affiliation: Toronto General Hospital, Toronto, Ontario, Canada. joanne.bargman@uhn.on.ca
authors.forename: Joanne M
authors.initials: JM
authors.lastname: Bargman
authors.forename: Raymond T
authors.initials: RT
authors.lastname: Krediet
authors.forename: Wai Kei
authors.initials: WK
authors.lastname: Lo
authors.forename: Rafael
authors.initials: R
authors.lastname: Selgas
authors.forename: Gloria
authors.initials: G
authors.lastname: del Peso
authors.forename: M
authors.initials: M
authors.lastname: Auxiliadora Bajo
authors.forename: Salim
authors.initials: S
authors.lastname: Mujais
mesh_terms: D001692:Biological Transport / Q000502:physiology; D015314:Dialysis Solutions / Q000493:pharmacokinetics*; D050171:Dyslipidemias / Q000209:etiology / Q000378:metabolism; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism / Q000628:therapy*; D010530:Peritoneal Dialysis / Q000009:adverse effects / Q000379:methods*; D010537:Peritoneum / Q000378:metabolism*; D012307:Risk Factors; D013997:Time Factors
chemical_list: D015314:Dialysis Solutions